Zobrazeno 1 - 10
of 225
pro vyhledávání: '"C, Balmaceda"'
Publikováno v:
PharmacoEconomics Open
Purpose The aim of this study was to evaluate the cost effectiveness of cladribine compared with alemtuzumab, natalizumab, and ocrelizumab for the treatment of highly active multiple sclerosis (HAD-MS) from the perspective of the Chilean health care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e49f73bf00a4440bffe3ef0172a854
http://europepmc.org/articles/PMC8611154
http://europepmc.org/articles/PMC8611154
Publikováno v:
Value in Health. 25:S127-S128
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60cd911cbaf3ca04b5f68d1f0f5a7612
https://doi.org/10.1016/j.jval.2022.09.615
https://doi.org/10.1016/j.jval.2022.09.615
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 22:101-106
This study aimed to estimate the expected cost of hypoglycemia in Diabetes Mellitus type-2 patients receiving hypoglycemic treatment in Chile and to explore the effect of the potential reduction of hypoglycemia over the total cost incurred by its pub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b836dd90b1d75e231149546fb884e7b
https://doi.org/10.1080/14737167.2021.1865808
https://doi.org/10.1080/14737167.2021.1865808
Publikováno v:
Value in Health. 25:S152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf1f9a85761250ce62f3c79a01a0dd10
https://doi.org/10.1016/j.jval.2022.09.735
https://doi.org/10.1016/j.jval.2022.09.735
Publikováno v:
Value in Health. 25:S105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea0ebb606acaf6dae9a7efe127f5d40
https://doi.org/10.1016/j.jval.2022.09.512
https://doi.org/10.1016/j.jval.2022.09.512
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Public Health
BMC Public Health
Background Musculoskeletal disorders are a leading cause of disability adjusted life years (DALY) in the world. We aim to describe the prevalence and to compare the DALYs and loss of health state utilities (LHSU) attributable to common musculoskeleta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad18b8b55681187e8afdae3a55674180
https://doi.org/10.1186/s12889-021-10953-z
https://doi.org/10.1186/s12889-021-10953-z
Autor:
María Elena Ceballos, Nicole Le Corre, Sergio Vargas-Salas, Alvaro Huete, Bruno Nervi, Carolina Selman, Jaime Santander, Fernando Valiente-Echeverría, Luis Villarroel, Luis Rojas, Franz Villarroel-Espíndola, C. Balmaceda, Mayling Chang, Ricardo Soto-Rifo, María Elvira Balcells, Patricio Ross, Mauricio Sarmiento, Constanza Martínez-Valdebenito, Alejandra Pizarro, Ricardo Castro, Marcela Ferrada, Mauricio Mahave, Christian Caglevic, Carolina Beltrán-Pavez, Jaime Pereira, Barbara Lara, Manuel Espinoza, Cecilia Vizcaya, José Luis Briones, Marcela Ferrés, Sebastian Mondaca, Raimundo Gazitúa
Publikováno v:
PLoS Medicine, Vol 18, Iss 3, p e1003415 (2021)
PLoS Medicine
PLoS medicine, 18(3):e1003415
PLoS Medicine
PLoS medicine, 18(3):e1003415
Background Convalescent plasma (CP), despite limited evidence on its efficacy, is being widely used as a compassionate therapy for hospitalized patients with COVID-19. We aimed to evaluate the efficacy and safety of early CP therapy in COVID-19 progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c6d7e9ea82f0075ef7a423b72bf82d
https://doaj.org/article/cad36da3c89d489a88e5f731d6d4f0ea
https://doaj.org/article/cad36da3c89d489a88e5f731d6d4f0ea
Autor:
Antonio Ahumada-Canale, Victoria Garcia-Cardenas, Francisco Martinez-Mardones, Shalom I. Benrimoj, C. Balmaceda, C. Vargas, José Cristian Plaza-Plaza
Publikováno v:
Journal of comparative effectiveness research. 10(3)
Aim: To assess the trial-based cost–effectiveness of medication review with follow-up compared with usual care in primary care. Materials & methods: A cluster randomized controlled trial included patients if they were independent older adults, rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462e62935cb03710b0e82cb07a74a0d9
https://pubmed.ncbi.nlm.nih.gov/33543637
https://pubmed.ncbi.nlm.nih.gov/33543637
Autor:
Marcela Ferrés, Luis Rojas, Luis Villarroel, Carolina Selman, Barbara Lara, Bruno Nervi, María Elena Ceballos, Franz Villarroel-Espíndola, Raimundo Gazitúa, Sergio Vargas-Salas, Sebastian Mondaca, Mauricio Mahave, Mayling Chang, Ricardo Soto-Rifo, Mauricio Sarmiento, Jaime Santander, C. Balmaceda, Marcela Ferrada, Ricardo Castro, Alejandra Pizarro, Manuel Espinoza, Christian Caglevic, Jaime Pereira, Carolina Beltrán-Pavez, María Elvira Balcells, Constanza Martínez-Valdebenito, Fernando Valiente-Echeverría, José Luis Briones, Cecilia Vizcaya, Patricio Ross, Nicole Le Corre, Alvaro Huete
BackgroundConvalescent plasma (CP), despite limited evidence on its efficacy, is being widely used as a compassionate therapy for hospitalized patients with COVID-19. We aimed to evaluate the efficacy and safety of early CP therapy in COVID-19 progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6da6e340fca2a3d0b684d01ff1cb1322
https://doi.org/10.1101/2020.09.17.20196212
https://doi.org/10.1101/2020.09.17.20196212
